MA25656A1 - Une methode pour le maintien ou le perfectionnement de la synthese des mucines. - Google Patents

Une methode pour le maintien ou le perfectionnement de la synthese des mucines.

Info

Publication number
MA25656A1
MA25656A1 MA26798A MA26798A MA25656A1 MA 25656 A1 MA25656 A1 MA 25656A1 MA 26798 A MA26798 A MA 26798A MA 26798 A MA26798 A MA 26798A MA 25656 A1 MA25656 A1 MA 25656A1
Authority
MA
Morocco
Prior art keywords
maintaining
improving
mucin synthesis
disease states
synthesis
Prior art date
Application number
MA26798A
Other languages
English (en)
Inventor
Olivier Ballevre
Denis Breuille
Paul-Andre Finot
Original Assignee
Nestle Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=27052980&utm_source=***_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=MA25656(A1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Priority claimed from US09/774,814 external-priority patent/US6833350B2/en
Application filed by Nestle Sa filed Critical Nestle Sa
Publication of MA25656A1 publication Critical patent/MA25656A1/fr

Links

Classifications

    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/115—Fatty acids or derivatives thereof; Fats or oils
    • A23L33/12—Fatty acids or derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/12—Antidiarrhoeals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/02—Nutrients, e.g. vitamins, minerals

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nutrition Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Mycology (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Obesity (AREA)
  • Food Science & Technology (AREA)
  • Polymers & Plastics (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
MA26798A 2000-02-04 2002-08-30 Une methode pour le maintien ou le perfectionnement de la synthese des mucines. MA25656A1 (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US49890500A 2000-02-04 2000-02-04
US09/774,814 US6833350B2 (en) 2000-02-04 2001-01-30 Method for maintaining or improving the synthesis of mucins

Publications (1)

Publication Number Publication Date
MA25656A1 true MA25656A1 (fr) 2002-12-31

Family

ID=27052980

Family Applications (1)

Application Number Title Priority Date Filing Date
MA26798A MA25656A1 (fr) 2000-02-04 2002-08-30 Une methode pour le maintien ou le perfectionnement de la synthese des mucines.

Country Status (22)

Country Link
EP (1) EP1255452B2 (fr)
JP (1) JP2003533436A (fr)
CN (1) CN1434681B (fr)
AT (1) ATE323422T1 (fr)
AU (1) AU784137B2 (fr)
BG (1) BG106967A (fr)
BR (1) BRPI0108096B1 (fr)
CA (1) CA2399063C (fr)
CZ (1) CZ20022978A3 (fr)
DE (1) DE60118888T3 (fr)
DZ (1) DZ3298A1 (fr)
ES (1) ES2261383T5 (fr)
HR (1) HRP20020647A2 (fr)
HU (1) HUP0204439A3 (fr)
IL (1) IL150977A (fr)
MA (1) MA25656A1 (fr)
MX (1) MXPA02007491A (fr)
NO (1) NO20023640L (fr)
NZ (1) NZ520605A (fr)
PL (1) PL357078A1 (fr)
SK (1) SK11212002A3 (fr)
WO (1) WO2001056405A2 (fr)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2382874A1 (fr) 2003-06-23 2011-11-02 Nestec S.A. Supplémentation d'acides aminés pour un écosystème microbiotique sain
WO2007004613A1 (fr) 2005-07-01 2007-01-11 Ajinomoto Co., Inc. Agent thérapeutique contre l'affection abdominale inflammatoire et inhibiteur de la production de tnf-α
CA2631220A1 (fr) * 2006-01-09 2007-07-19 Nestec S.A. Traitement de patients stresses
WO2012133198A1 (fr) * 2011-03-25 2012-10-04 イーエヌ大塚製薬株式会社 Composition nutritionnelle pour maladies inflammatoires
CN103813796A (zh) 2011-07-22 2014-05-21 雅培制药有限公司 用于预防胃肠道损伤和/或促进胃肠道修复的低聚半乳糖
EP3167895A1 (fr) * 2015-11-10 2017-05-17 University College Dublin Complément alimentaire contenant du bêta-glucane et d'hydrolysat de caséine pour améliorer la santé et la performance de croissance chez un mammifère

Family Cites Families (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2459620B1 (fr) * 1979-06-26 1983-08-05 Agronomique Inst Nat Rech Hydrolisat enzymatique total de proteines de lactoserum, obtention et application
US5162373A (en) * 1986-01-17 1992-11-10 Board Of Regents, The University Of Texas System Methods and improved formulations for the determination and treatment of malignant disease in patients
JP2631470B2 (ja) * 1987-05-15 1997-07-16 雪印乳業株式会社 感染防御剤
CA1338682C (fr) * 1988-12-23 1996-10-29 Gustavo Bounous Concentre de proteine non caseique, biologiquement actif, utile comme supplement alimentaire
JP2805490B2 (ja) * 1989-02-07 1998-09-30 雪印乳業株式会社 細菌毒素中和剤
JP3007694B2 (ja) * 1990-12-14 2000-02-07 雪印乳業株式会社 胃潰瘍予防または治療のための医薬及び飲食品
DE69331528T2 (de) * 1992-12-23 2002-10-31 Abbott Laboratories, Abbott Park Medizinische nahrungsmittel für die ernährungsergänzung bei metabolischen erkrankungen von säuglingen/kleinkindern
NZ248605A (en) * 1993-05-28 1994-12-22 Abbott Lab Enteral nutritional product comprising protein and fat
FR2711529B1 (fr) * 1993-10-28 1996-07-05 Clintec Nutrition Cy Composition à base d'acides aminés destinée au traitement d'une infection ou d'une agression engendrant une réaction inflammatoire, chez les animaux et chez l'homme.
JPH07267855A (ja) * 1994-03-30 1995-10-17 Taiho Yakuhin Kogyo Kk グルタミン産生剤
US5952314A (en) * 1994-04-01 1999-09-14 Demichele; Stephen Joseph Nutritional product for a person having ulcerative colitis
US5728678A (en) * 1995-06-06 1998-03-17 Nestec Ltd. Method and composition for providing nutrition to a renal failure patient
US5670157A (en) * 1995-12-11 1997-09-23 Nestec Ltd. Method for reducing and controlling immunoglobulin concentrations
US5922766A (en) * 1997-07-02 1999-07-13 Acosta; Phyllis J. B. Palatable elemental medical food
AU9625498A (en) * 1997-09-16 1999-04-05 Societe Des Produits Nestle S.A. Organ specific nutrition
CA2331921A1 (fr) * 1998-06-24 1999-12-29 Boyce Thompson Institute For Plant Research, Inc. Nouvel adnc mucin intestinal des invertebres et produits et procedes correspondants
EP1034704A1 (fr) * 1999-03-12 2000-09-13 Societe Des Produits Nestle S.A. Composition nutritionnelle notamment pour la maturation gastro-intestinale spécifique dans des mammifères prématurés
EP1222275A2 (fr) * 1999-10-22 2002-07-17 The Board of Regents of the University of Nebraska Isoforme de serum amyloide a decouverte dans le colostrum

Also Published As

Publication number Publication date
DE60118888T3 (de) 2010-09-23
HUP0204439A2 (hu) 2003-04-28
NO20023640D0 (no) 2002-07-31
JP2003533436A (ja) 2003-11-11
DZ3298A1 (fr) 2001-08-09
AU4056401A (en) 2001-08-14
HRP20020647A2 (en) 2004-12-31
HUP0204439A3 (en) 2004-12-28
MXPA02007491A (es) 2002-12-13
DE60118888T2 (de) 2007-01-18
WO2001056405A3 (fr) 2002-01-24
EP1255452B2 (fr) 2010-03-03
PL357078A1 (en) 2004-07-12
CZ20022978A3 (cs) 2003-02-12
ES2261383T5 (es) 2010-06-18
ATE323422T1 (de) 2006-05-15
CN1434681A (zh) 2003-08-06
IL150977A0 (en) 2003-02-12
CN1434681B (zh) 2010-12-08
WO2001056405A2 (fr) 2001-08-09
BG106967A (bg) 2003-04-30
BRPI0108096B1 (pt) 2017-05-09
NZ520605A (en) 2004-06-25
NO20023640L (no) 2002-09-19
EP1255452A2 (fr) 2002-11-13
CA2399063A1 (fr) 2001-08-09
BR0108096A (pt) 2002-10-29
IL150977A (en) 2005-09-25
SK11212002A3 (sk) 2003-01-09
DE60118888D1 (de) 2006-05-24
AU784137B2 (en) 2006-02-09
EP1255452B1 (fr) 2006-04-19
ES2261383T3 (es) 2010-06-14
CA2399063C (fr) 2014-01-28

Similar Documents

Publication Publication Date Title
TW200503708A (en) Gyrase inhibitors and uses thereof
DE60325945D1 (de) Zusammensetzungen und verfahren für die behandlung von mikroorganismen-infektionen
CY1110230T1 (el) Αναστολεις γυρασης και χρησεις αυτων
EP1673078A4 (fr) Inhibiteurs de type benzylether et benzylamino de beta-secretase pour le traitement de la maladie d'alzheimer
WO2005004803A3 (fr) Inhibiteurs de la beta-secretase de phenylcarboxylate destines au traitement de la maladie d'alzheimer
IL147271A0 (en) Compounds that bind her2
WO2003077828A3 (fr) Antibiotiques de type florfenicol
TW200621766A (en) Substituted hydantoins
WO2001098317A3 (fr) Alpha-glycosylceramides destines au traitement d'infections bacteriennes et fongiques
TW200621764A (en) Substituted hydantoins
TNSN00007A1 (fr) Macrolides nouveaux, procede pour leur preparation et compositions pharmaceutiques les contenant
MXPA03011546A (es) Formulacion farmaceutica.
WO2005051914A8 (fr) Inhibiteurs de benzylether et benzylamino de beta-secretase pour traiter la maladie d'alzheimer
HUP0100566A2 (hu) Új eritromicinszármazékok
EA200601607A1 (ru) Сульфонамидные соединения для лечения нейродегенеративных расстройств
WO2005037839A8 (fr) Composes derives de norcantharidine, leurs procedes de preparation, les compositions les contenant et leurs utilisations.
MA25656A1 (fr) Une methode pour le maintien ou le perfectionnement de la synthese des mucines.
EA200300066A1 (ru) Производные аминоалкоксибензоил-бензофурана или бензотиофена, способ их получения и содержащие их композиции
WO2007019078A3 (fr) Inhibiteurs de la beta-secretase tricyclique pour traiter la maladie d'alzheimer
BRPI0409609A (pt) mediadores do transporte reverso de colesterol para o tratamento da hipercolesterolemia
YU58102A (sh) Postupak za održavanje ili poboljšanje sinteze mucina
NO20014788D0 (no) En sammensetning for senkning av konsentrasjonen av sykdomsfremkallende tarmpeptider
WO2005021575A3 (fr) Molecules de signalisation bacterienne regulant en les diminuant les proprietes de virulence pathogene bacterienne
DE602004019500D1 (en) 4-substituirte-5-cyano-1h-pyrimidin-6-(th)iones als als gsk-3-hemmer
TW200504036A (en) Novel lactams and uses thereof